← Market

Health · Fda Purple Book

FDA Purple Book licensed biological products matching a name (brand or proper name, e.g. adalimumab): applicant, BLA number, license type (351(a) originator, 351(k) biosimilar or interchangeable), strength, dosage form, route, marketing status, approval date, reference product and exclusivity expiry dates, plus the products newly approved or updated this month. From FDA's monthly Purple Book data download.

GET https://api.healthtravel-api.workers.dev/api/health/fda-purple-book

0.002 USDC on Base · payTo 0xb8491F953e6860D3b5840b73c60883Ff099ceAfA

Status: unverified (probe-pending)

Settlement: direct to the seller's payTo — 0% HIVE402 take

Payment routes